EEPD1 and neoplasm: Characterizing expression levels of MUS81, EEPD1, and Metnase may help illuminate tumor resistance to traditional therapeutics and inform personalized treatments, such as higher genotoxin doses to counteract the enhanced replication stress resistance associated with overexpression of these nucleases.